Compare Oscar Health Inc (OSCR) vs Sezzle Inc (SEZL) Price & Performance

Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.

The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.

Sezzle Inc. (SEZL) trades at $171.76, down 1.67% today, with a bullish technical signal from moving averages and a neutral RSI near 50. The stock shows strong fundamental momentum, with Q1 2026 EPS of $1.43 beating estimates of $1.24, and robust profitability metrics including a 30.83% net income margin and 91.95% ROE. Recent news highlights subscriber growth of 48.4% year-over-year and product expansions, supporting the positive sentiment.

Outlook remains favorable due to consistent earnings beats and raised guidance, but risks include high valuation multiples (P/E of 41) and competitive pressures in the BNPL sector. Analyst consensus is a Moderate Buy with a $162 price target, suggesting potential downside from current levels, though the high target of $190 indicates upside if growth persists.